Request Demo
Last update 28 Jun 2025
Sorafenib/MG-005
Last update 28 Jun 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms GW5074/Sorafenib, MG005/Sorafenib, Sorafenib/GW5074 + [4] |
Target |
Action inhibitors |
Mechanism Raf kinase inhibitors(RAF serine/threonine protein kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC21H16ClF3N4O3 |
InChIKeyMLDQJTXFUGDVEO-UHFFFAOYSA-N |
CAS Registry284461-73-0 |
Related
1
Clinical Trials associated with Sorafenib/MG-005NCT00941863
Phase I Study to Determine the Safety, Maximum Tolerated Dose, PK of BAY43-9006 in Repeated Cycles of 18 Days On/3 Days Off in Combination With Paclitaxel and Carboplatin Chemotherapy in Patients With Advanced, Refractory Solid Tumors
100 Clinical Results associated with Sorafenib/MG-005
Login to view more data
100 Translational Medicine associated with Sorafenib/MG-005
Login to view more data
100 Patents (Medical) associated with Sorafenib/MG-005
Login to view more data
100 Deals associated with Sorafenib/MG-005
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Phase 1 | China | 06 Jun 2018 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free